120 related articles for article (PubMed ID: 554446)
1. A controlled double-blind study of haloperidol versus thioridazine in the treatment of restless mentally subnormal patients. Serum levels and clinical effects.
Väisänen K; Rimón R; Räisänen P; Viukari M
Acta Psychiatr Belg; 1979; 79(6):673-85. PubMed ID: 554446
[TBL] [Abstract][Full Text] [Related]
2. Haloperidol, thioridazine and placebo in mentally subnormal patients-serum levels and clinical effects.
Väisänen K; Viukari M; Rimón R; Räisänen P
Acta Psychiatr Scand; 1981 Mar; 63(3):262-71. PubMed ID: 7015792
[TBL] [Abstract][Full Text] [Related]
3. Haloperidol treatment with chronically medicated residents: dose effects on clinical behavior and reinforcement contingencies.
Aman MG; Teehan CJ; White AJ; Turbott SH; Vaithianathan C
Am J Ment Retard; 1989 Jan; 93(4):452-60. PubMed ID: 2649118
[TBL] [Abstract][Full Text] [Related]
4. Plasma propranolol levels and their effect on plasma thioridazine and haloperidol concentrations.
Greendyke RM; Kanter DR
J Clin Psychopharmacol; 1987 Jun; 7(3):178-82. PubMed ID: 3597804
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of thioridazine and mesoridazine on the QT interval in healthy adults after single oral doses.
Salih IS; Thanacoody RH; McKay GA; Thomas SH
Clin Pharmacol Ther; 2007 Nov; 82(5):548-54. PubMed ID: 17410120
[TBL] [Abstract][Full Text] [Related]
6. Effects of thioridazine dosage on the behavior of severely mentally retarded persons.
Singh NN; Aman MG
Am J Ment Defic; 1981 May; 85(6):580-7. PubMed ID: 7023237
[TBL] [Abstract][Full Text] [Related]
7. Effect of pindolol administration on serum levels of thioridazine, haloperidol, phenytoin, and phenobarbital.
Greendyke RM; Gulya A
J Clin Psychiatry; 1988 Mar; 49(3):105-7. PubMed ID: 3346197
[TBL] [Abstract][Full Text] [Related]
8. Very low-dose neuroleptic treatment in two patients with agitation associated with Alzheimer's disease.
Risse SC; Lampe TH; Cubberley L
J Clin Psychiatry; 1987 May; 48(5):207-8. PubMed ID: 2883174
[TBL] [Abstract][Full Text] [Related]
9. Blood levels of haloperidol and thioridazine during maintenance neuroleptic treatment of schizophrenic outpatients.
Shvartsburd A; Sajadi C; Morton V; Mirabi M; Gordon J; Smith RC
J Clin Psychopharmacol; 1984 Aug; 4(4):194-8. PubMed ID: 6470190
[TBL] [Abstract][Full Text] [Related]
10. Droperidol vs. haloperidol in the initial management of acutely agitated patients.
Resnick M; Burton BT
J Clin Psychiatry; 1984 Jul; 45(7):298-9. PubMed ID: 6376480
[TBL] [Abstract][Full Text] [Related]
11. A double-blind randomized clinical trial of rapid tranquilization with I.M. clonazepam and I.M. haloperidol in agitated psychotic patients with manic symptoms.
Chouinard G; Annable L; Turnier L; Holobow N; Szkrumelak N
Can J Psychiatry; 1993 Nov; 38 Suppl 4():S114-21. PubMed ID: 8306241
[TBL] [Abstract][Full Text] [Related]
12. Mesoridazine and thioridazine: clinical effects and blood levels in refractory schizophrenics.
Vital-Herne J; Gerbino L; Kay SR; Katz IR; Opler LA
J Clin Psychiatry; 1986 Jul; 47(7):375-9. PubMed ID: 2873133
[TBL] [Abstract][Full Text] [Related]
13. A double-blind controlled study of intramuscular zuclopenthixol acetate and liquid oral haloperidol in the treatment of schizophrenic patients with acute exacerbation.
Chouinard G; Safadi G; Beauclair L
J Clin Psychopharmacol; 1994 Dec; 14(6):377-84. PubMed ID: 7884017
[TBL] [Abstract][Full Text] [Related]
14. Effect of anticonvulsants on plasma haloperidol and thioridazine levels.
Linnoila M; Viukari M; Vaisanen K; Auvinen J
Am J Psychiatry; 1980 Jul; 137(7):819-21. PubMed ID: 6770696
[TBL] [Abstract][Full Text] [Related]
15. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
Künzel HE; Ackl N; Hatzinger M; Held K; Holsboer-Trachsler E; Ising M; Kaschka W; Kasper S; Konstantinidis A; Sonntag A; Uhr M; Yassouridis A; Holsboer F; Steiger A
J Psychiatr Res; 2009 Apr; 43(7):702-10. PubMed ID: 19038406
[TBL] [Abstract][Full Text] [Related]
16. Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam.
Currier GW; Chou JC; Feifel D; Bossie CA; Turkoz I; Mahmoud RA; Gharabawi GM
J Clin Psychiatry; 2004 Mar; 65(3):386-94. PubMed ID: 15096079
[TBL] [Abstract][Full Text] [Related]
17. Analysis of single, double-blind procedures, maintenance of placebo effects, and drug-induced dyskinesia with mentally retarded persons--a brief report [proceedings].
Breuning SE; Ferguson DG; Cullari S
Psychopharmacol Bull; 1981 Jan; 17(1):122-3. PubMed ID: 7232641
[No Abstract] [Full Text] [Related]
18. Haloperidol versus thioridazine in the treatment of behavioral symptoms in senile dementia of the Alzheimer's type: preliminary findings.
Steele C; Lucas MJ; Tune L
J Clin Psychiatry; 1986 Jun; 47(6):310-2. PubMed ID: 3711028
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of thioridazine in the elderly.
Cohen BM; Sommer BR
J Clin Psychopharmacol; 1988 Oct; 8(5):336-9. PubMed ID: 3183071
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive treatment of manic agitation with lorazepam versus haloperidol: a double-blind study.
Lenox RH; Newhouse PA; Creelman WL; Whitaker TM
J Clin Psychiatry; 1992 Feb; 53(2):47-52. PubMed ID: 1541605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
